2018 in review: Alzheimer’s falters while oncology shinesGoing into 2018 you might have expected this to be the year of Alzheimer’s drugs, with several promising Share X2018 in review: Alzheimer’s falters while oncology shineshttps://pharmaphorum.com/r-d/views-analysis-r-d/2018-review-alzheimers-research-oncology/
Eisai accelerates dementia drug discovery researchEisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the Share XEisai accelerates dementia drug discovery researchhttps://pharmaphorum.com/news/eisai-dementia-drug-research/
